HIV and HCV Intervention In Drug Treatment Settings - 1
Completed · Phase 3
Conditions studied: Behavior Therapy
In brief
The purpose of this study is to test two strategies to reduce the risk of contracting Human Immunodeficiency Virus (HIV) or Hepatitis C Virus (HCV) by reducing risk behaviors in patients undergoing drug detoxification.
Key facts
- Study ID
- NCT00102349
- Run by
- University of Colorado, Denver
- People needed
- 706
- Starts
- 2004-11-01
- Expected to finish
- 2006-02-01
- Last updated by the study team
- 2017-01-12
Who can join
Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Denver Health & Hosp Authority — Denver, Colorado, United States
- Island Grove RTC — Greeley, Colorado, United States
- SSTAR (Stanley St. Treatment & Resources, Inc) — Fall River, Massachusetts, United States
- James Gilmore Jr. Treatment Center — Kalamazoo, Michigan, United States
- Willamette Family Treatment Services — Eugene, Oregon, United States
- SSTAR of Rhode Island - North Kingstown — North Kingstown, Rhode Island, United States
- Recovery Center King Co.-Kent Detox — Kent, Washington, United States
- Recovery Center King Co.-Seattle Detox — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.